MedTrace Logo

Probiotics and Influenza Vaccination Response

NCT05690373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-08-24

No results posted yet for this study

Summary

Assess efficacy of oral ingestion of a probiotic product on immune function in a population of healthy adult men and women in a clinical vaccination study.

Conditions

  • Vaccine Response

Interventions

DIETARY_SUPPLEMENT

Probiotic effect on influenza vaccine response

Seroconversion rate: the percentage of subjects achieving at least a 4-fold increase or an increase from \>10 to 40 in Ab titre for seronegative subjects.

Sponsors & Collaborators

  • NIZO Food Research

    collaborator OTHER

  • The Archer-Daniels-Midland Company

    lead INDUSTRY

Principal Investigators

  • Alwine Kardinaal, PhD · NIZO food research B.V

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05690373 on ClinicalTrials.gov